Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael B Yaffe

Showing results (151-160 of 267) with videos related to

Pageof 27
Sort By:
Cancer Research|April 22, 2010
Impaired SHP2-mediated extracellular signal-regulated kinase activation contributes to gefitinib sensitivity of lung cancer cells with epidermal growth factor receptor-activating mutationsMatthew J Lazzara, Keara Lane, Richard Chan, et al.
The Journal of Experimental Medicine|August 2, 2006
The phosphoinositide-binding protein p40phox activates the NADPH oxidase during FcgammaIIA receptor-induced phagocytosisChang-Il Suh, Natalie D Stull, Xing Jun Li, et al.
Nature|July 11, 2008
Polo-like kinase-1 is activated by aurora A to promote checkpoint recoveryLibor Macůrek, Arne Lindqvist, Dan Lim, et al.
Cell Reports|November 19, 2013
A reversible gene-targeting strategy identifies synthetic lethal interactions between MK2 and p53 in the DNA damage response in vivoSandra Morandell, H Christian Reinhardt, Ian G Cannell, et al.
Cell Cycle (Georgetown, Tex.)|February 21, 2013
Single-cell microarray enables high-throughput evaluation of DNA double-strand breaks and DNA repair inhibitorsDavid M Weingeist, Jing Ge, David K Wood, et al.
The EMBO Journal|April 21, 2007
Proteomic screen defines the Polo-box domain interactome and identifies Rock2 as a Plk1 substrateDrew M Lowery, Karl R Clauser, Majbrit Hjerrild, et al.
The Journal of Cell Biology|February 28, 2002
14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transportAnne Brunet, Fumihiko Kanai, Justine Stehn, et al.
Molecular Cancer Therapeutics|June 11, 2009
The antiproliferative cytostatic effects of a self-activating viridin prodrugAdam Smith, Joseph Blois, Hushan Yuan, et al.
Nature Communications|January 27, 2024
Activation of GPR3-β-arrestin2-PKM2 pathway in Kupffer cells stimulates glycolysis and inhibits obesity and liver pathogenesisTing Dong, Guangan Hu, Zhongqi Fan, et al.
Journal of Thrombosis and Haemostasis : JTH|April 9, 2020
Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case seriesJanice Wang, Negin Hajizadeh, Ernest E Moore, et al.
Pageof 27

Showing results (151-160 of 267) with videos related to

Sort By:
Pageof 27
Cancer Research|April 22, 2010
Impaired SHP2-mediated extracellular signal-regulated kinase activation contributes to gefitinib sensitivity of lung cancer cells with epidermal growth factor receptor-activating mutationsMatthew J Lazzara, Keara Lane, Richard Chan, et al.
The Journal of Experimental Medicine|August 2, 2006
The phosphoinositide-binding protein p40phox activates the NADPH oxidase during FcgammaIIA receptor-induced phagocytosisChang-Il Suh, Natalie D Stull, Xing Jun Li, et al.
Nature|July 11, 2008
Polo-like kinase-1 is activated by aurora A to promote checkpoint recoveryLibor Macůrek, Arne Lindqvist, Dan Lim, et al.
Cell Reports|November 19, 2013
A reversible gene-targeting strategy identifies synthetic lethal interactions between MK2 and p53 in the DNA damage response in vivoSandra Morandell, H Christian Reinhardt, Ian G Cannell, et al.
Cell Cycle (Georgetown, Tex.)|February 21, 2013
Single-cell microarray enables high-throughput evaluation of DNA double-strand breaks and DNA repair inhibitorsDavid M Weingeist, Jing Ge, David K Wood, et al.
The EMBO Journal|April 21, 2007
Proteomic screen defines the Polo-box domain interactome and identifies Rock2 as a Plk1 substrateDrew M Lowery, Karl R Clauser, Majbrit Hjerrild, et al.
The Journal of Cell Biology|February 28, 2002
14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transportAnne Brunet, Fumihiko Kanai, Justine Stehn, et al.
Molecular Cancer Therapeutics|June 11, 2009
The antiproliferative cytostatic effects of a self-activating viridin prodrugAdam Smith, Joseph Blois, Hushan Yuan, et al.
Nature Communications|January 27, 2024
Activation of GPR3-β-arrestin2-PKM2 pathway in Kupffer cells stimulates glycolysis and inhibits obesity and liver pathogenesisTing Dong, Guangan Hu, Zhongqi Fan, et al.
Journal of Thrombosis and Haemostasis : JTH|April 9, 2020
Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case seriesJanice Wang, Negin Hajizadeh, Ernest E Moore, et al.
Pageof 27